DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Gruppo R, Chen H, Schroth P, Bray GL.
Safety and immunogenicity of recombinant factor VIII (Recombinate) in previously untreated patients: a 7.3 year update.
Haemophilia 1998; 4: 228 (abstract no. 291, XXIII Congress of the WFH, The Hague).
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.